1. You Are At:
  2. English News
  3. Health
  4. COVID India Updates: How worrying is 'variant' first seen in India

COVID India Updates: How worrying is 'variant' first seen in India

The second strain of the COVID is quite dangerous and has left people struggling to get rid of the same. At the same time, vaccination drive is also going on at a great rate in the country. And while all of this is happening, there are a lot of people spreading rumours about the pandemic. Know the answer to your every question related to the deadly virus here.

Health Desk Health Desk
New Delhi Updated on: May 18, 2021 23:35 IST
COVID-19 variant
Image Source : FILE IMAGE

How worrying is the 'COVID-19 variant' first seen in India

COVID India Updates: The number of coronavirus cases surged when the second wave hit the country badly. People went in search of oxygen cylinders, hospital beds, injections, etc. Well, after weeks of extended lockdowns and night curfews, various states are experiencing a fall in the daily COVID cases, leaving people with a sigh of relief. The second strain of the COVID is quite dangerous and has left people struggling to get rid of the same. At the same time, vaccination drive is also going on at a great rate in the country. And while all of this is happening, there are a lot of people spreading rumours about the pandemic. Know the answer of your every question related to the deadly virus here:

 

 

 

COVID India Updates

Auto Refresh
Refresh
  • 10:51 PM (IST) Posted by Ridhi Suri

    Covaxin clinical trials for 2-18 age group to begin in next 10-12 days

    The clinical trials of Bharat Biotech's Covaxin in the age group of 2-18 years will begin in next 10-12 days, the government said Tuesday. The development comes days after India's apex drugs regulator granted permission for conducting the phase II/III clinical trials on children. 

    "COVAXIN has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days," Dr. VK Paul, Member-Health, Niti Aayog said at a press conference today. 

  • 10:50 PM (IST) Posted by Ridhi Suri

    New COVID strain in Singapore: Here's what India doing

    Aviation Minister Hardeep Singh Puri Tuesday said the Centre is taking all precautions and keeping an eye on the situation in Singapore after Delhi Chief Minister Arvind Kejriwal appealed to it to cancel all flights with the city-state as a "very dangerous" coronavirus strain has been detected there.

    "Kejriwal ji, all international flights have been stopped since March 2020. We have no air bubble with Singapore either," Puri said on Twitter.

    Read the full story

  • 10:48 PM (IST) Posted by Ridhi Suri

    Maharashtra COVID cases

    Maharashtra recorded as many as 28,438 coronavirus cases on Tuesday, taking the tally of infections in the state to 54,33,506, the death toll increased to 83,777 with 679 new fatalities. As many as 52,898 patients were discharged from hospitals, taking the number of recovered patients to 49,27,480, The number of active cases stands at 4,19,727. Maharashtra's recovery rate of COVID-19 cases is 90.69 per cent, while the fatality rate is 1.54 per cent.

  • 9:02 PM (IST) Posted by Ridhi Suri

    Haryana Home Minister Anil Vij: In all medical colleges, 20-20 bed wards have been prepared for black fungus patients. All civil hospitals have been told that if they have any case of black fungus, they should send it to the medical colleges, where all the facilities of black fungus are being provided

  • 8:13 PM (IST) Posted by Ridhi Suri

    State-wise stats of the population that received at least one dose of COVID Vaccine

  • 8:12 PM (IST) Posted by Ridhi Suri

    COVID19: Positivity Rate

  • 8:06 PM (IST) Posted by Ridhi Suri

    Delhi receives over 60,000 Covaxin doses for 45-plus, key workers

    Delhi on Tuesday received over 60,000 Covaxin doses for key workers and those aged above 45, AAP MLA Atishi said. Still, the city has only two days of Covaxin stock left for this category, while Covishield doses for the group can last up to four days, she said.

    She also said that 1.13 lakh beneficiaries received jabs on May 17. Around 10.75 lakh people have got both the doses since the inoculation drive began on January 16.

  • 8:05 PM (IST) Posted by Ridhi Suri

    The COVID-19 variant first identified in India has been classified as a “variant of concern” by Britain and the World Health Organisation, meaning there is some evidence that it spreads more easily between people, causes more severe disease, or might be less responsive to treatments and vaccines.

     

    Read the full story

  • 6:21 PM (IST) Posted by Vaishali Jain

    A steep rise in digestive issues post-Covid, find doctors

    Closure of all outdoor avenues for physical activity and exercise and an increase in stress levels as people are trying to deal with illness, loss of loved ones and financial losses are having an adverse impact on the overall health and well-being and especially on digestive health.

    Click here for details

  • 5:49 PM (IST) Posted by Vaishali Jain

    Breaking myths!

  • 3:18 PM (IST) Posted by Vaishali Jain

    Total spend of $ 8 billion on Covid vaccines for India in 2021

    A supply-based model for India's Covid-19 vaccinations developed by international bank Investec estimates a total spend of Rs 750 billion ($ 8 billion) for calendar year 2021 including Rs 32 billion by April for India as a whole including centre, states and private sector. Based on current supply visibilities (imports / India mfg / new launches), 75% of India's population (above 18 years of age) will get vaccinated by October'21, Investec said.

    This assumes all of the manufactured / imported vaccine can be administered by India's existing health care infrastructure setup.

    -- IANS

  • 1:33 PM (IST) Posted by Vaishali Jain

    Sputnik debuts on CoWin app

    Sputnik V, the Russian COVID-19 vaccine being produced in India by Dr Reddy's Laboratory has made its debut on the CoWIN platform on May 18

    Click here for details!

  • 1:17 PM (IST) Posted by Shriya Bhasin

    New variant of COVID threatens immunity, Swami Ramdev shares Ayurvedic remedies for heart, lungs

  • 1:16 PM (IST) Posted by Shriya Bhasin

    Get rid of weakness caused by COVID, know remedy from Swami Ramdev for full recovery

  • 1:16 PM (IST) Posted by Shriya Bhasin
  • 1:15 PM (IST) Posted by Shriya Bhasin

    In the battle against this virus, our weapons are local containment zone, aggressive testing and sending correct and complete information to the people. You all are playing a very important role in the battle against Corona. In a way, you are the field commanders of this battle: PM Modi

  • 1:15 PM (IST) Posted by Shriya Bhasin
  • 1:14 PM (IST) Posted by Shriya Bhasin

    PM Modi interacted with field officials from States and Districts to converse about their experience in handling the #COVID19 pandemic on Tuesday.

  • 1:08 PM (IST) Posted by Shriya Bhasin

    The Russian COVID-19 vaccine Sputnik V which is being produced in India by Dr. Reddy's Laboratory has made debut on the CoWIN application on May 18.

     

  • 11:58 AM (IST) Posted by Vaishali Jain

    India witnesses worst Covid toll as 4,329 die in a day

    With 4,329 deaths in last 24 hours, India on Tuesday recorded highest fatalities from Covid infection, the Union Ministry of Health and Family Welfare said.

    However, there was a bright side as well, as 2,63,533 new cases reported i the same duration -- were the lowest in 26 days. On Monday, the number of Covid cases has come down below the three-lakh- mark for the first time since April 21.

  • 10:38 AM (IST) Posted by Vaishali Jain

    Can Covid-19 vaccines get adulterated?

    "We have strong immunisation networks, however, we need to be extra vigilant in this case, as any adverse situation will have a long impact. The Covid vaccine can save a life, but a falsified vaccine will kill human beings as well erode public confidence in healthcare systems, healthcare professionals, and government agencies," Nakul Pasricha, Chief Executive of Pharma Secure, a company that offers drug verification technology to pharmaceutical companies in India, told IANS.

    "Greater risk of harm to consumers will result in greater liability for healthcare providers. Circulation of falsified or fake vaccines will add to the already overwhelming crisis that the country is facing thus hampering the efforts of our governments, healthcare organisations, and our frontline warriors," he added.

  • 9:30 AM (IST) Posted by Shriya Bhasin

    Smokers and vegetarians have less risk of COVID-19, know the truth of this claim

    CSIR India news claimed that smokers and vegetarians are at less risk of corona after which a tweet was made by the Government of India. In the same, it was said that this is absolutely wrong news. The tweet stated that at present there is no conclusion based on serological studies that people who eat vegetarian food and smoke have a lower risk of getting infected.

     

X